Xikang Cloud Hospital Holdings (HKSE:09686) Research & Development: HK$35.9 Mil (TTM As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

HKSE:09686 Xikang Cloud Hospital Holdings Inc HKSE:09686
21 GF Score
Price HK$0.86
! 3 Warning Signs
View Full Analysis

What is Xikang Cloud Hospital Holdings Research & Development?

Xikang Cloud Hospital Holdings HKSE:09686 21 Research & Development is HK$35.9 Mil as of Dec. 2025. GuruFocus rates HKSE:09686 with a GF Score™ of 21/100. The stock has 3 warning signs investors should review.

Research & Development is the aggregate amount of research and development expenses during the year. Xikang Cloud Hospital Holdings's Research & Development for the six months ended in Dec. 2025 was HK$14.5 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Dec. 2025 was HK$35.9 Mil.

Xikang Cloud Hospital Holdings  (HKSE:09686) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Xikang Cloud Hospital Holdings Research & Development Related Terms

Xikang Cloud Hospital Holdings Research & Development Historical Data

* Premium members only.

The historical data trend for Xikang Cloud Hospital Holdings's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Xikang Cloud Hospital Holdings Research & Development Chart

Xikang Cloud Hospital Holdings Annual Data
Trend Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Research & Development
Get a 7-Day Free Trial 105.82 88.18 60.79 44.85 36.12

Xikang Cloud Hospital Holdings Semi-Annual Data
Dec20 Dec21 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Research & Development Get a 7-Day Free Trial Premium Member Only 30.41 22.90 22.14 21.39 14.50
HKSE:09686
21GF Score
Xikang Cloud Hospital Holdings Inc HKSE:09686
Research & Development is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Xikang Cloud Hospital Holdings Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Dec. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was HK$35.9 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of HK$35.9 Mil mean?
Xikang Cloud Hospital Holdings (HKSE:09686) has a Research & Development of HK$35.9 Mil as of Dec. 2025. Research and development expense is the total cost for research and development activities. View historical data on Xikang Cloud Hospital Holdings and its competitors.
Is Xikang Cloud Hospital Holdings' Research & Development too high?
Xikang Cloud Hospital Holdings' current Research & Development is HK$35.9 Mil. Overall, Xikang Cloud Hospital Holdings has a GF Score™ of 21/100, reflecting its overall financial health beyond just this single metric.
How does Xikang Cloud Hospital Holdings' Research & Development compare to VEEV and BTSG?
Xikang Cloud Hospital Holdings' Research & Development of HK$35.9 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for a Healthcare Providers & Services company?
A good Research & Development depends on the Healthcare Providers & Services industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on Xikang Cloud Hospital Holdings and its competitors. Xikang Cloud Hospital Holdings's current Research & Development is HK$35.9 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Xikang Cloud Hospital Holdings stock overvalued right now?
Xikang Cloud Hospital Holdings (HKSE:09686) has a current Research & Development of HK$35.9 Mil. The current Research & Development is HK$35.9 Mil. Xikang Cloud Hospital Holdings' overall GF Score™ is 21/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For Xikang Cloud Hospital Holdings (HKSE:09686), the current Research & Development is HK$35.9 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Xikang Cloud Hospital Holdings Business Description

Address No. 12 Huizheng Alley, No. 1-1, 1-2, 1-3, 1-4, 1-5, 2-1, Haishu District, Zhejiang Province, Ningbo, CHN
Xikang Cloud Hospital Holdings Inc an investment holding company, and its subsidiaries are principally engaged in the provision of medical services, nursing services and health management services in the People's Republic of China. As an operator of Internet + Nursing Services, the Group has consistently positioned at-home medical and care services as its core strategic focus to accelerate the development and expansion of city-specific cloud hospital platforms within the smart healthcare ecosystem. It has established a full-chain digital medical service system covering medical treatment, nursing, and health management. Its segments are: medical services, nursing services, and health management services, with health management services generating maximum revenue from the Chinese mainland.
21GF Score

Get the complete analysis for HKSE:09686

Research & Development is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

HK$0.86
Price